Company Filing History:
8 out of 2,405 
4 out of 28 
1 out of 35 Years Active: 2017-2025
Title: **Hyewon Youm: Innovator in Cyclic Polypeptide Research**
Introduction
Hyewon Youm is a distinguished inventor based in Berkeley Heights, New Jersey, known for her significant contributions to the field of cyclic polypeptides. With a remarkable portfolio of 8 patents, she has made strides in the pharmaceutical industry, particularly in the development of innovative methods for cholesterol management.
Latest Patents
One of Hyewon's latest patents is focused on cyclic polypeptides for PCSK9 inhibition. The patent details compounds that specifically bind to human proprotein convertase subtilisin/kexin type 9 (PCSK9), and optionally inhibit the interaction between PCSK9 and the human low-density lipoprotein receptor (LDLR). In addition, the patent outlines pharmaceutical compositions comprising these cyclic polypeptide compounds and methods for reducing LDL cholesterol levels in subjects in need of such treatment.
Career Highlights
Throughout her career, Hyewon Youm has collaborated with leading companies in the pharmaceutical sector, including Merck Sharp & Dohme Corporation and Ra Pharmaceuticals, Inc. Her work in these organizations has furthered the development of groundbreaking therapies aimed at addressing critical health issues related to cholesterol levels in patients.
Collaborations
Hyewon has worked alongside talented coworkers such as Yusheng Xiong and Thomas Joseph Tucker. These collaborations have played a crucial role in advancing her research and have contributed to the growth of innovative therapeutic solutions in the medical field.
Conclusion
Hyewon Youm's dedication to innovation and research in cyclic polypeptides exemplifies her impact on the pharmaceutical industry. Her patents and collaborations reflect a commitment to improving health outcomes through scientific advancements, positioning her as a notable inventor in her domain.